As of Feb 05
| -4.26 / -9.69%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 105.00, with a high estimate of 235.00 and a low estimate of 69.00. The median estimate represents a +164.35% increase from the last price of 39.72.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.